Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1959 1
1961 1
1963 1
1967 1
1973 1
1980 1
1981 4
1982 1
1983 4
1984 2
1985 3
1986 3
1987 6
1988 9
1989 6
1990 11
1991 10
1992 10
1993 12
1994 13
1995 13
1996 16
1997 13
1998 11
1999 14
2000 24
2001 32
2002 44
2003 72
2004 98
2005 96
2006 103
2007 126
2008 134
2009 146
2010 183
2011 201
2012 189
2013 269
2014 228
2015 270
2016 306
2017 303
2018 274
2019 272
2020 323
2021 300
2022 313
2023 260
2024 270
2025 240

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

4,749 results

Results by year

Filters applied: . Clear all
Page 1
Multicenter, Randomized, Phase III Trial of Short-Term Radiotherapy Plus Chemotherapy Versus Long-Term Chemoradiotherapy in Locally Advanced Rectal Cancer (STELLAR).
Jin J, Tang Y, Hu C, Jiang LM, Jiang J, Li N, Liu WY, Chen SL, Li S, Lu NN, Cai Y, Li YH, Zhu Y, Cheng GH, Zhang HY, Wang X, Zhu SY, Wang J, Li GF, Yang JL, Zhang K, Chi Y, Yang L, Zhou HT, Zhou AP, Zou SM, Fang H, Wang SL, Zhang HZ, Wang XS, Wei LC, Wang WL, Liu SX, Gao YH, Li YX. Jin J, et al. Among authors: li yh. J Clin Oncol. 2022 May 20;40(15):1681-1692. doi: 10.1200/JCO.21.01667. Epub 2022 Mar 9. J Clin Oncol. 2022. PMID: 35263150 Free PMC article. Clinical Trial.
Combined anti-PD-1, HDAC inhibitor and anti-VEGF for MSS/pMMR colorectal cancer: a randomized phase 2 trial.
Wang F, Jin Y, Wang M, Luo HY, Fang WJ, Wang YN, Chen YX, Huang RJ, Guan WL, Li JB, Li YH, Wang FH, Hu XH, Zhang YQ, Qiu MZ, Liu LL, Wang ZX, Ren C, Wang DS, Zhang DS, Wang ZQ, Liao WT, Tian L, Zhao Q, Xu RH. Wang F, et al. Among authors: li yh. Nat Med. 2024 Apr;30(4):1035-1043. doi: 10.1038/s41591-024-02813-1. Epub 2024 Mar 4. Nat Med. 2024. PMID: 38438735 Clinical Trial.
Final Overall Survival Analysis of Gemcitabine and Cisplatin Induction Chemotherapy in Nasopharyngeal Carcinoma: A Multicenter, Randomized Phase III Trial.
Zhang Y, Chen L, Hu GQ, Zhang N, Zhu XD, Yang KY, Jin F, Shi M, Chen YP, Hu WH, Cheng ZB, Wang SY, Tian Y, Wang XC, Sun Y, Li JG, Li WF, Li YH, Mao YP, Zhou GQ, Sun R, Liu X, Guo R, Long GX, Liang SQ, Li L, Huang J, Long JH, Zang J, Liu QD, Zou L, Su QF, Zheng BM, Xiao Y, Guo Y, Han F, Mo HY, Lv JW, Du XJ, Xu C, Liu N, Li YQ, Xie FY, Sun Y, Ma J, Tang LL. Zhang Y, et al. Among authors: li yh. J Clin Oncol. 2022 Aug 1;40(22):2420-2425. doi: 10.1200/JCO.22.00327. Epub 2022 Jun 16. J Clin Oncol. 2022. PMID: 35709465 Clinical Trial.
Interferon-α stimulates DExH-box helicase 58 to prevent hepatocyte ferroptosis.
Jia KW, Yao RQ, Fan YW, Zhang DJ, Zhou Y, Wang MJ, Zhang LY, Dong Y, Li ZX, Wang SY, Wang M, Li YH, Zhang LX, Lei T, Gui LC, Lu S, Yang YY, Wang SX, Yu YZ, Yao YM, Hou J. Jia KW, et al. Among authors: li yh. Mil Med Res. 2024 Apr 15;11(1):22. doi: 10.1186/s40779-024-00524-9. Mil Med Res. 2024. PMID: 38622688 Free PMC article.
A prognostic survival nomogram for persons with extra-nodal natural killer-/T-cell lymphoma.
Wang H, Fu BB, Wuxiao ZJ, Li YJ, Huang L, Ma J, Zhai ZM, Guo J, Wu YB, Xu ZS, Feng J, Zhou SS, Chen TT, Chen XG, Li GW, Liu TZ, Huang HB, Zheng RH, Li YH, Tao HF, Zi FM, Wu F, Wang J, Zeng H, Fu CB, Gale RP, Xia ZJ, Liang Y. Wang H, et al. Among authors: li yh. Leukemia. 2022 Nov;36(11):2724-2728. doi: 10.1038/s41375-022-01679-x. Epub 2022 Aug 15. Leukemia. 2022. PMID: 35970944 No abstract available.
4,749 results